Table 4: Sociodemographic characteristics of study participants.
|
Variable |
Treatment Group |
Chi Square |
P Value |
|||||
|
Cetrizine n (%) |
Nonsaponi n (%) |
Otrivine n (%) |
Saponi n (%) |
Shea n (%) |
Steroid n (%) |
|||
|
Gender |
||||||||
|
Male |
2 (25.0) |
0 (0.0) |
3 (50) |
2 (28.6) |
2 (25.0) |
1 (16.7) |
4.675f |
0.5 |
|
Female |
6 (75.0) |
7 (100.0) |
3 (50) |
5 (71.4) |
6 (75.0) |
5 (83.3) |
||
|
Age |
||||||||
|
45-49 |
2 (25.0) |
0 (0.0) |
0 (0.0) |
1 (14.3) |
0 (0.0) |
0 (0.0) |
29.417 f |
0.223 |
|
40-44 |
0 (0.0) |
1 (14.3) |
0 (0.0) |
2 (28.6) |
3 (37.5) |
0 (0.0) |
||
|
35-39 |
1 (12.5) |
2 (28.6) |
2 (33.3) |
0 (0.0) |
2 (25.0) |
1 (16.7) |
||
|
30-34 |
1 (12.5) |
1 (14.3) |
1 (16.7) |
0 (0.0) |
0 (0.0) |
2 (33.3) |
||
|
25-29 |
1 (12.5) |
0 (0.0) |
1 (16.7) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
||
|
18-24 |
3 (37.5) |
0 (0.0) |
2 (33.3) |
2 (28.6) |
3 (37.5) |
2 (33.3) |
||
|
>= 50 |
0 (0.0) |
3 (4.29) |
0 (0.0) |
2 (28.6) |
0 (0.0) |
1 (16.7) |
||
|
Refining |
||||||||
|
Yes |
2 (25.0) |
1 (14.3) |
0 (0.0) |
2 (28.6) |
0 (0.0) |
1 (16.7) |
4.131 f |
0.586 |
|
No |
6 (75.0) |
6 (85.7) |
6 (100.0) |
5 (71.4) |
8 (100.0) |
5 (83.3) |
||
|
Residence |
||||||||
|
Urban |
3 (37.5) |
5 (71.4) |
4 (66.7) |
7 (100.0) |
6 (75.00 |
5 (83.3) |
10.425 f |
0.273 |
|
SemiUrban |
4 (50.0) |
1 (14.3) |
1 (16.7) |
0 (0.0) |
2 (25.0) |
0 (0.0) |
||
|
Rural |
1 (12.5) |
1 (14.3) |
1 (16.7) |
0 (0.0) |
0 (0.0) |
1 (16.7) |
||